Chemicals and intermediates used in pharmaceutical manufacturing and drug development.
chemXplore tracks 177 projects in pharma, of which 67 are active.
Of the active ones, 37 expansion, 27 new construction and 3 revamp / retrofit.
24 active projects carry no start-up date yet. The dates themselves, per project, are for subscribers.
In the 24-week Phase 4 STAR trial, both dosing schedules improved BASDAI scores and reduced sacroiliac inflammation versus placebo.
In the REAL8 trial, 105 children had comparable growth rates after 52 weeks on weekly somapacitan-beco or daily somatropin.
Two Phase 3 trials found symptom improvement by Day 3, sustained through Week 3; approval would add another adult use.
The designation is supported by phase I/Ib trial data; phase III studies are under way, with second-line results expected in the second half of 2027.
The accelerated approval covers adults with advanced disease after alectinib alone, or after at least two ALK inhibitors and platinum chemotherapy.
AI and automated equipment design, run and evaluate API process experiments, with reported throughput of up to 100 experiments a day.
The deal would add OLN324, a Phase 3 bispecific antibody candidate for retinal diseases, to its ophthalmology pipeline.
In the phase 3 STEP Young trial, BMI fell over 68 weeks with semaglutide alongside diet and activity changes; the treatment remains investigational for children under 12 in the US.
Findings span an ovariectomized-rat model, small human biomarker studies and exploratory analyses from the 68-week REDEFINE 1 trial.
The oral giredestrant–everolimus regimen cut the risk of progression or death by 62% versus endocrine therapy plus everolimus in phase III testing.
active all projects
The 8 with the most active projects, of 27 countries.